The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…
Articles by Forest Ray PhD
Pharming Group has committed to building a new manufacturing facility in the Netherlands to expand production of Ruconest…
Icatibant injection, a generic form of Firazyr from Fresenius Kabi, is now available to adults in the…
Takeda Canada announced reaching an agreement for public funding in Canada of Takhzyro (lanadelumab), its treatment for eligible…
KalVista Pharmaceuticals is planning to initiate a Phase 2 trial of its investigational oral therapy KVD824 as a…
A single dose of NTLA-2002, Intellia Therapeutics’ investigational gene-editing therapy for hereditary angioedema (HAE), induces sustained reductions…
In cases where targeted treatment for hereditary angioedema (HAE) is not available for rapid management of swelling attacks, patients…
Bridge Medicines and The Rockefeller University are collaborating to treat hereditary angioedema (HAE) by developing a series…
Short-term preventive treatment with Berinert, a plasma-derived form of the C1 inhibitor protein, protects people with hereditary and…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography…